---
title: "35 stocks received buy ratings from institutions today, with 6 stocks having an upside potential exceeding 20%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230486965.md"
description: "Today, institutional research reports released 43 buy ratings, involving 35 stocks. Willfar received 4 buy ratings, and 6 stocks have an upside potential of over 20%. NMHD has the highest upside potential, with a target price of 5.54 yuan, representing a 46.95% increase. The 6 stocks that institutions are focusing on for the first time include BEST, Fulin Precision, and others. The average increase for stocks with institutional buy ratings today was 1.49%, with 24 stocks rising. The top gainers include Kaide Quartz, Xiling Power, and Bawei Co., while the largest decliners include Lihu Co., BeiGene, and LiuGong"
datetime: "2025-03-04T12:42:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230486965.md)
  - [en](https://longbridge.com/en/news/230486965.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230486965.md)
generator: "portal-rs"
---

# 35 stocks received buy ratings from institutions today, with 6 stocks having an upside potential exceeding 20%

According to data from Data Treasure, today a total of 43 buy ratings were released by institutions, involving 35 individual stocks. Willfar received the highest attention, with 4 buy ratings from institutions. Among the stocks rated as buy today, there are 9 ratings that provided future target prices for the relevant stocks.

Comparing the published target prices with the latest closing prices shows that 6 stocks have an upside potential of over 20%. NMHD has the highest upside potential, with Huatai Securities estimating the company's target price at 5.54 yuan on March 4, indicating an upside potential of 46.95%. Other stocks with high upside potential include Sanfeng Environment and Trina Solar, with upside potentials of 38.50% and 35.53%, respectively. In terms of changes in institutional ratings, among today's buy ratings, there are 6 records that represent the first attention from institutions, involving BEST, Fulin Precision, and 4 other stocks. In terms of market performance, stocks rated as buy by institutions rose an average of 1.49% today, outperforming the Shanghai Composite Index. There were 24 stocks that saw price increases, with the largest gains from Kaide Quartz, Xiling Power, and Bawei Co., which rose by 12.67%, 10.29%, and 7.62%, respectively. Stocks with significant declines include Lihu Co., BeiGene, and LiuGong, with declines of 8.60%, 4.49%, and 1.52%, respectively

### Related Stocks

- [600863.CN](https://longbridge.com/en/quote/600863.CN.md)
- [300580.CN](https://longbridge.com/en/quote/300580.CN.md)
- [688100.CN](https://longbridge.com/en/quote/688100.CN.md)
- [300694.CN](https://longbridge.com/en/quote/300694.CN.md)
- [688599.CN](https://longbridge.com/en/quote/688599.CN.md)
- [06886.HK](https://longbridge.com/en/quote/06886.HK.md)
- [000528.CN](https://longbridge.com/en/quote/000528.CN.md)
- [300432.CN](https://longbridge.com/en/quote/300432.CN.md)
- [300733.CN](https://longbridge.com/en/quote/300733.CN.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [601827.CN](https://longbridge.com/en/quote/601827.CN.md)

## Related News & Research

- [Cantor mulls giving institutional clients access to Kalshi's prediction markets - report](https://longbridge.com/en/news/296354352.md)
- [Heart Aerospace Just Flew The Aviation Transition Investors Should Be Putting Billions Into](https://longbridge.com/en/news/296674386.md)
- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)
- [13:27 ETTop Enterprise Architecture Platforms Named 2026 Champions in Info-Tech Research Group's Emotional Footprint Report](https://longbridge.com/en/news/296641619.md)
- [14:41 ETNine Corboy & Demetrio Attorneys selected to 2027 The Best Lawyers in America®](https://longbridge.com/en/news/296644470.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**